Sign in

CIK 0001739410

  • Emerging growth company

Rallybio Corp

Sign in to watch
Ticker
RLYB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851083789
Phone
+1 203-859-3820
Business address
234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
Former names
Rallybio Holdings, LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Fryer Jeffrey M bought 1,400 shares at $8.70 ($12,180)
  3. 4 Open-market buy Uden Stephen bought 10,000 shares at an average $9.85 ($98,502)
  4. 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $10.35 ($103,473)
  5. 4 Open-market buy Fryer Jeffrey M bought 10,000 shares at an average $9.41 ($94,069)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 615,384 shares at $13.00 ($7,999,992)
  12. 4 Open-market buy 10% owner bought 615,384 shares at $13.00 ($7,999,992)
  13. 3/A Insider 3/A
  14. 4 Open-market buy Director bought 576,923 shares at $13.00 ($7,499,999)
  15. 4 Open-market buy Director bought 307,692 shares at $13.00 ($3,999,996)
  16. 4 Open-market buy Director bought 76,923 shares at $13.00 ($999,999)
  17. 4 Conversion FMR LLC acquired 1,694,388 shares (conversion)
  18. 4 Open-market buy 10% owner bought 806,000 shares at $13.00 ($10,478,000)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 6 of 7 · 132 filings